Our managing director, Dr Elisabeth Adams, is presenting two posters at the 30th annual International Papillomavirus Conference in Lisbon, Portugal. The first poster, “Exploring the value of a rapid, on-demand test for the detection of human papillomavirus”, is a detailed look at the current patient pathways for cervical screening programmes, and key opinion leaders’ views on the impact a rapid diagnostic would have on the health and overall wellbeing of women.
Faster answers for better outcomes
Rapid diagnostics are revolutionising the way that clinical decisions are made. Rapid diagnostic technology can yield better results for patients, healthcare providers, and the wider population when introduced in the right way. We can help you understand the options for implementing rapid diagnostics into current care pathways, and can quantify the costs, benefits and impact. This gives you the evidence to support better healthcare delivery.
Straight answers for sensitive questions
As research leaders in sexual health, we have seen our published work impact on international policy and patient care. We have experience in estimating the impact of introducing innovation such as rapid tests into sexual health services, delivering care in new ways, and understanding the burden of disease on society.